LESLIE CASTEEL: Open Payments
NPI 1851918841 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,429 in 81 payments from 19 companies in 2025. Trend: 2023 $601 · 2024 $1,142 · 2025 $1,429
Food & beverage: $1,429
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $365 |
| Amgen Inc. | 12 | $174 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $138 |
| Otsuka America Pharmaceutical, Inc. | 5 | $91 |
| PFIZER INC. | 5 | $91 |
| Lilly USA, LLC | 5 | $91 |
| ABBVIE INC. | 5 | $82 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $64 |
| Xeris Pharmaceuticals, Inc. | 2 | $48 |
| Inspire Medical Systems, Inc. | 2 | $46 |
Products named: Rybelsus, CAPLYTA, OTEZLA, REXULTI, Wegovy, Ozempic, JARDIANCE, VRAYLAR.
Industry payments across TN — which companies pay providers there.
